CDMOs offering ADC Payload & Linker Synthesis with Peptide
8 published
8 published CDMOs match ADC Payload & Linker Synthesis and Peptide.
Locations in this set include United States, United Kingdom, Ireland, China, France, and India.
Capabilities that show up most often in this set: API Synthesis & Manufacturing, CMC Analytical Development, HPAPI Manufacturing (High-Potency), Peptide Manufacturing, and Process Development.
Matching companies
- BSP PharmaceuticalsBSP Pharmaceuticals is a CDMO specializing in development and manufacturing of cytotoxic oncology drugs, ADCs, peptides, proteins, and lipid-based formulations from preclinical GLP through commercial supply.
FluorochemFluorochem supplies over 400,000 high-quality chemicals and reagents globally, with custom synthesis and contract manufacturing capabilities for pharmaceutical and life sciences research.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Piramal Pharma SolutionsCDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management.
SK pharmtecoSK pharmteco is a CDMO offering comprehensive drug development and manufacturing services.
Sterling Pharma SolutionsSmall molecule CDMO offering comprehensive API development and manufacturing from discovery through commercial cGMP production, with specialized expertise in complex and hazardous chemistries and ADC bioconjugation.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
VeranovaGlobal CDMO specializing in development and manufacturing of complex active pharmaceutical ingredients (APIs), with expertise in solid form sciences, process development, and specialty modalities including ADCs and controlled substances.
Markdown mirror: /explore/adc-payload-synthesis/peptide.md